Clinical Trial Update: Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies [Phase 1]

View source ↗

Summary

Terminated Phase 1 clinical trial evaluating the combination of ATRA-IV and Depakote in patients with advanced solid tumor malignancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• ATRA-IV (all-trans retinoic acid)
• DEPAKOTE (DIVALPROEX SODIUM)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Solid Tumor Malignancies | Phase 1 | Status: TERMINATED